Can you help interpret the CT angiogram findings in a 27‑year‑old female with Shone complex, which show stable post‑treatment aortic changes with mild ectasia distal to the aortic arch, no clear supravalvular membrane, and a possible bicuspid aortic valve?

CT Angiography Interpretation in Shone Complex with Bicuspid Aortic Valve

Your patient's CT angiogram shows reassuring stability of prior aortic interventions with mild post-stenotic dilation, a likely bicuspid aortic valve requiring confirmation and surveillance, and importantly excludes a supravalvular membrane—all findings that necessitate structured long-term monitoring given her complex congenital heart disease.

Key Findings Breakdown

Stable Post-Treatment Aortic Changes with Mild Ectasia

• The "stable posttreatment changes" indicate prior surgical or interventional management of her Shone complex, with mild ectasia (dilation) immediately distal to the aortic arch representing expected post-stenotic changes rather than progressive aortopathy 1.
• This mild ectasia distal to the arch is common in patients with prior coarctation repair or left-sided obstructive lesions and requires serial monitoring 1.
• Serial imaging with CT angiography or cardiac MRI should be performed annually if the aortic diameter exceeds 4.0 cm, or every 3-5 years if smaller 1.

No Supravalvular Membrane

• The absence of a compelling supravalvular membrane is clinically significant in Shone complex, as this represents one of the multiple potential left-sided obstructive lesions (subaortic stenosis, bicuspid aortic valve, supravalvular stenosis, coarctation, parachute mitral valve) that define this syndrome 1.
• This finding helps stratify her disease burden and suggests she has an incomplete form of Shone complex 2.
• Echocardiography should still be performed to assess for discrete subaortic membranes or tunnel-like obstruction that may be better visualized with Doppler interrogation 1.

Possible Bicuspid Aortic Valve

• The "possible" bicuspid valve requires definitive characterization, as bicuspid aortic valve (BAV) occurs in 1-2% of the general population and is frequently associated with Shone complex 1, 3, 4.
• Transthoracic echocardiography is the primary modality to confirm BAV anatomy, assess valve function (stenosis vs. regurgitation), and measure aortic dimensions at the annulus, sinuses of Valsalva, sinotubular junction, and mid-ascending aorta 1.
• BAV patients have a 50% incidence of associated aortopathy independent of valve dysfunction, with intrinsic medial abnormalities predisposing to progressive dilation 5, 3, 6.

Immediate Management Steps

Confirm Bicuspid Valve Anatomy and Function

• Obtain comprehensive transthoracic echocardiography with Doppler to definitively establish BAV morphology (fusion pattern), quantify any stenosis (peak velocity, mean gradient, valve area) or regurgitation (jet width, vena contracta, regurgitant volume), and assess left ventricular function and dimensions 1.
• The fusion pattern matters: right-noncoronary cusp fusion has higher prevalence of aortic dilation (68%) compared to right-left coronary cusp fusion (40%) 1.
• Doppler interrogation of the proximal descending aorta should evaluate for residual or recurrent coarctation 1.

Complete Aortic Imaging

• Since CT angiography cannot fully assess the aortic root and may have missed segments, obtain cardiac MRI (preferred over repeat CT to minimize radiation in this young patient) to comprehensively image the entire aorta from sinuses to descending aorta 1.
• MRI provides superior soft tissue characterization, accurate diameter measurements using the double-oblique technique, and assessment of valve function without radiation exposure 1.
• Measurements should be performed at standardized anatomic landmarks: aortic annulus, sinuses of Valsalva, sinotubular junction, mid-ascending aorta, and transverse arch 1.

Screen for Additional Shone Complex Components

• Echocardiography must specifically evaluate for congenital mitral stenosis, parachute mitral valve, supramitral ring, and discrete subaortic membrane—the other potential components of Shone complex 1.
• Adults with congenital mitral stenosis or parachute mitral valve should be systematically evaluated for other left-sided obstructive lesions 1.

Surveillance Strategy

Aortic Monitoring Protocol

• If aortic diameter is >4.5 cm at any segment, perform annual imaging with echocardiography, cardiac MRI, or CT angiography 1.
• If aortic diameter is 4.0-4.5 cm, perform imaging every 1-2 years depending on rate of progression and family history 1.
• If aortic diameter is <4.0 cm and stable, perform imaging every 3-5 years 1, 5.
• The mean rate of aortic diameter progression in BAV patients is 0.5-0.9 mm/year at different segments, though rates up to 2 mm/year have been reported 1.

Valve Function Monitoring

• If moderate valve dysfunction (stenosis or regurgitation) is present, perform annual transthoracic echocardiography to assess left ventricular function, dimensions, and hemodynamic progression 1, 5.
• Annual clinical evaluation for symptom development (dyspnea, angina, syncope) is critical, as symptoms drive intervention timing 1.
• Consider NT-pro BNP levels when anatomic severity and clinical symptoms are discordant 5.

Surgical Thresholds

• Operative intervention for the ascending aorta is indicated when diameter exceeds 5.5 cm in BAV patients 1.
• Earlier intervention at 5.0 cm may be considered in BAV patients with additional risk factors: rapid growth (>0.5 cm/year), family history of dissection, or concomitant aortic valve surgery 1, 6.
• For subaortic stenosis (if present), surgical intervention is recommended when maximum gradient ≥50 mmHg with symptoms, or with lesser gradients if heart failure, ischemic symptoms, or LV dysfunction are present 1.
• Prophylactic subaortic membrane resection may be considered with gradient ≥50 mmHg and at least mild aortic regurgitation to prevent progressive valvular damage 1.

Critical Pitfalls to Avoid

• Do not assume CT angiography alone provides complete assessment—echocardiography is essential for valve characterization and Doppler hemodynamics 1.
• Do not use surgical thresholds for tricuspid aortic valve disease in BAV patients—BAV requires lower intervention thresholds due to intrinsic aortopathy 1, 6.
• Do not forget to screen first-degree relatives, as 20-30% of BAV patients have affected family members 1.
• Do not use the same imaging modality inconsistently—MRI/CT measurements are 1-2 mm larger than echocardiography due to wall inclusion and timing differences 1.
• Do not overlook the need for multidisciplinary aortic team evaluation when surgical thresholds are approached, particularly in complex congenital cases 6.

Special Considerations in Shone Complex

• Shone complex represents multiple levels of left-sided obstruction (subaortic stenosis, bicuspid aortic valve, supravalvular stenosis, coarctation, parachute mitral valve, supramitral ring), and your patient appears to have an incomplete variant 1, 2.
• The presence of multiple obstructive lesions increases complexity of surgical planning and may require staged or combined interventions 1.
• Subaortic stenosis carries a 10-15% risk of complete heart block with surgical resection and tends to recur, particularly when initially resected in childhood 1.
• At 27 years old, this patient requires lifelong surveillance with an adult congenital heart disease (ACHD) cardiologist experienced in complex left-sided obstructive lesions 1.